Inventor · disambiguated record
Jeffrey S. Sabol
Also filed as: SABOL JEFFREY · SABOL JEFFREY S · SABOL JEFFREY STEPHEN
16 granted patents·2 pending applications·111 citations·filing 1985–2009
92Inventor score
Files withAVENTIS PHARMA INC6MERRELL DOW PHARMA5MERRELL PHARMA INC3ALDOUS SUZANNE C2HOECHST MARION ROUSSEL INC1
Top patents by PatentIndex Score
18 records- 0187US7326792B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2004·Granted Feb 5, 2008·29 cites·26 claims
- 0285US7741493B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2007·Granted Jun 22, 2010·8 cites·10 claims
- 0380US7169925B2Indole derivatives as interleukin-4 gene expression inhibitorsAVENTIS PHARMA INC·Filed 2003·Granted Jan 30, 2007·14 cites·11 claims
- 0478US5248825ACalcium uptake inhibitorsMERRELL DOW PHARMA·Filed 1992·Granted Sep 28, 1993·16 cites·10 claims
- 0573US8258130B2Pyrimidine hydrazide compounds as PGDS inhibitorsALDOUS SUZANNE C·Filed 2009·Granted Sep 4, 2012·5 cites·24 claims
- 0669US8202863B2Pyrimidine amide compounds as PGDS inhibitorsALDOUS SUZANNE C·Filed 2008·Granted Jun 19, 2012·2 cites·28 claims
- 0757US5760210AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1996·Granted Jun 2, 1998·5 cites·1 claims
- 0857US5512678A5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agentsMERRELL PHARMA INC·Filed 1994·Granted Apr 30, 1996·9 cites·8 claims
- 0957US5508393AProcess for the preparation of ribonucleotide reductase inhibitorsHOESCHST MARION ROUSSEL INC·Filed 1995·Granted Apr 16, 1996·7 cites·3 claims
- 1054US5589587AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1995·Granted Dec 31, 1996·8 cites·3 claims
- 1149US5223518A1-phenyl-3-aryl-2-propyne-1-one useful as calcium uptake inhibitorsMERRELL DOW PHARMA·Filed 1992·Granted Jun 29, 1993·3 cites·9 claims
- 1247US4622422ACyclohexanealkanoic acidsMERRELL DOW PHARMA·Filed 1985·Granted Nov 11, 1986·3 cites·9 claims
- 1344US7132256B2Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthaseAVENTIS PHARMA INC·Filed 2005·Granted Nov 7, 2006·0 cites·12 claims
- 1442US2007259384A1Methods for Determining the Potency, Specificity, and Toxicity of Hematopoietic Prostaglandin D2 SynthaseAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
- 1538US2004082021A1Method for assaying compounds or agents for ability to decrease the activity of microsomal prostaglandin E synthase or hematopoietic prostaglandin D synthaseAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 1637US6017923ACarbo-acyclic nucleoside derivatives as antiviral and antineoplastic agentsHOECHST MARION ROUSSEL INC·Filed 1996·Granted Jan 25, 2000·1 cites·26 claims
- 1737US5446068A1-phenyl-3-phenyl-2-propyne-1-ones as calcium uptake inhibitorsMERRELL DOW PHARMA·Filed 1994·Granted Aug 29, 1995·1 cites·11 claims
- 1832US5409942ACalcium uptake inhibitorsMERRELL DOW PHARMA·Filed 1993·Granted Apr 25, 1995·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →